ELUT supply chain intelligence for Elutia Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Elutia Inc. (ELUT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BERKELEY | BERKELEY | 92% | SimpliDerm is now supplied to Elutia through a long-term supply agreement with Berkeley, the acquiror of our Orthobiologics Business. |
| COOK-BIOTECH-INCORPORATED | COOK-BIOTECH-INCORPORATED | 92% | The porcine SIS-ECM for our Cardiovascular products is supplied by Cook Biotech Incorporated ("Cook"), now owned by Evergen, through a long-term supply agreement. |
| COOK | Traeger, Inc. | 90% | Reciprocal relationship from COOK graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from COOK graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from COOK g… |
| EVERGEN | EVERGEN | 80% | The porcine SIS-ECM for our Cardiovascular products is supplied by Cook Biotech Incorporated ("Cook"), now owned by Evergen, through a long-term supply agreement. |
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: our commercial partners and independent sales agents, which subjects us to various risks; ● because we depend upon a l… |
| BSX | Boston Scientific Corporation | 72% | our commercial partners and independent sales agents, which subjects us to various risks; ● because we depend upon a limited number of third-party suppliers and manufacturers and, in certain cases, e… |
| LGND | Ligand Pharmaceuticals Incorporated | 72% | Reciprocal relationship from LGND graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from LGND graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from LGND g… |
| MDT | Medtronic plc | 72% | ves to further expand our footprint and accelerate our sales. 78 Table of Contents We also sell legacy products into the Cardiovascular market. In Cardiovascular, we sell our specialized porcine sm… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from ELUT graph: ves to further expand our footprint and accelerate our sales. 78 Table of Contents We also sell legacy products into… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BSX | Boston Scientific Corporation | 72% | Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from BSX graph: Reciprocal relationship from ELUT graph: CanGaroo, are sold through both our i… |
| BSX | Boston Scientific Corporation | 72% | CanGaroo, are sold through both our internal sales force and independent sales agents and our commercial 25 Table of Contents partner, Boston Scientific Corporation. We believe the commercializatio… |
| LGND | Ligand Pharmaceuticals Incorporated | 72% | Reciprocal relationship from LGND graph: Reciprocal relationship from ELUT graph: Reciprocal relationship from LGND graph: Reciprocal relationship from ELUT graph: largely stabilize, or increase at m… |
| LGND | Ligand Pharmaceuticals Incorporated | 72% | largely stabilize, or increase at modest rates, in the near future through the identification of efficiencies as we grow. We may, however, still experience more significant expense increases to the e… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from ELUT graph: ned structural integrity and superior handling capabilities, which may mitigate inflammation and enhance tissue incorp… |
| MDT | Medtronic plc | 72% | ned structural integrity and superior handling capabilities, which may mitigate inflammation and enhance tissue incorporation, leading to a better healing experience as compared to other ADM products… |
| BERKELEY-BIOLOGICS-LLC | BERKELEY-BIOLOGICS-LLC | 62% | uence; ● our ability to raise funds in the future in the amounts and at the times needed; ● the continued and future acceptance of our products by the medical community; ● our dependence on independe… |
| CARDIAC-PACEMAKERS-INC | CARDIAC-PACEMAKERS-INC | 62% | uence; ● our ability to raise funds in the future in the amounts and at the times needed; ● the continued and future acceptance of our products by the medical community; ● our dependence on independe… |
| CORMATRIX-CARDIOVASCULAR-INC | CORMATRIX-CARDIOVASCULAR-INC | 62% | Less: current operating lease liabilities ( 355 ) Long-term operating lease liabilities $ 3,587 Note 9. Intangible Assets On May 31, 2017, the Company completed an asset purchase agreem… |
| MEDTRONIC-SOFAMOR-DANEK-USA-INC | MEDTRONIC-SOFAMOR-DANEK-USA-INC | 62% | are our next-generation biologic scaffolds combined with local antibiotic delivery; any statements and information concerning our future interactions with the U.S. Food and Drug Administration (“FDA”… |
| SWK-FUNDING-LLC | SWK-FUNDING-LLC | 62% | Less: current operating lease liabilities ( 355 ) Long-term operating lease liabilities $ 3,587 Note 9. Intangible Assets On May 31, 2017, the Company completed an asset purchase agreem… |
| TIGER-AESTHETICS-MEDICAL-LLC | TIGER-AESTHETICS-MEDICAL-LLC | 62% | are our next-generation biologic scaffolds combined with local antibiotic delivery; any statements and information concerning our future interactions with the U.S. Food and Drug Administration (“FDA”… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ELUT-DEBT-9274 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| ELUT-DEBT-9273 | Warrants outstanding: 607000 | 90% | xbrl warrant detail from xbrl 2025-12-31. |
| ELUT-DEBT | Debt stack $26.1M | 90% | Market cache reports total debt of $26.1M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| ELUT-OWNER-AIGH-CAPITAL-MANAGEMENT-LLC | AIGH Capital Management LLC | 90% | 13F overlay lists AIGH Capital Management LLC as top holder; 36 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| TLX | Telix Pharmaceuticals Limited | 100.00 | 2 | |
| PLSE | Pulse Biosciences, Inc. | 100.00 | 2 | |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 100.00 | 2 | |
| SGMO | Sangamo Therapeutics, Inc. | 100.00 | 2 | |
| OVID | Ovid Therapeutics Inc. | 100.00 | 2 | |
| LGND | Ligand Pharmaceuticals Incorporated | 100.00 | 1 | ['customer', 'supplier'] |
| DRTS | Alpha Tau Medical Ltd. | 100.00 | 2 | |
| LONA | LeonaBio, Inc. | 100.00 | 2 | |
| MDT | Medtronic plc | 100.00 | 1 | ['customer', 'supplier'] |
| PEN | Penumbra, Inc. | 100.00 | 2 | |
| NSPR | InspireMD, Inc. | 100.00 | 2 | |
| OBIO | Orchestra BioMed Holdings, Inc. | 100.00 | 2 | |
| CRMD | CorMedix Inc. | 100.00 | 2 | |
| AGEN | Agenus Inc. | 100.00 | 2 | |
| BSX | Boston Scientific Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| COOK | Traeger, Inc. | 100.00 | 1 | ['supplier'] |
| ICCM | IceCure Medical Ltd | 100.00 | 2 | |
| BWAY | BrainsWay Ltd. | 100.00 | 2 | |
| BNRG | Brenmiller Energy Ltd | 100.00 | 2 | |
| PLX | Protalix BioTherapeutics, Inc. | 100.00 | 2 |